Should I Buy TELA Bio (TELA)? Finance YouTuber Analysis

The YouTuber is buying TELA Bio, acknowledging it as the riskiest on the list but with potential. The medical device maker focuses on the large hernia repair and reconstructive surgery markets, showing strong revenue growth. However, its cash flow statement is poor, indicating a need for more research.

“The smallest penny stock on the list at just 104 million and probably the riskiest is tilab bio T tea a medical device maker designed designing and marketing tissue reinforcement materials for soft tissue reconstruction.”

The YouTuber is buying TELA, a medical device company focused on tissue reinforcement materials, due to its 45% revenue growth and improving gross profitability. While acknowledging it's deeply cash flow negative and financially risky, he believes its proven product and rapid sales ramp-up mitigate some of the risk, provided it has enough cash runway to grow.

“Tila grew Revenue by 45 over the last year to 12 million dollars even while improving gross profitability increasing the gross margin to 67 percent of sales”